Perampanel as precision therapy in rare genetic epilepsies (vol 64, pg 866, 2023)

A. Nissenkorn,G. Kluger,S. Schubert-Bast,A. Bayat, M. Bobylova,P. Bonanni,B. Ceulemans,A. Coppola,C. Di Bonaventura,M. Feucht, A. Fuchs,G. Groppel,G. Heimer, B. Herdt, S. Kulikova, K. Mukhin, S. Nicassio,A. Orsini, M. Panagiotou,M. Pringsheim, B. Fuest, O. Pylaeva,G. Ramantani, M. Tsekoura, P. Ricciardelli, T. Lerman Sagie, B. Stark,P. Striano,A. van Baalen,M. De Wachter,E. Cerulli Irelli,C. von Stulpnagel,A. Russo

EPILEPSIA（2024）

引用 7|浏览43

暂无评分

摘要

Perampanel demonstrated high safety and efficacy in patients with rare genetic epilepsies, especially in SCN1A, GNAO1, PIGA, PCDH19, SYNGAP1, CDKL5, NEU1 and POLG, suggesting a targeted effect related to glutamate transmission.

查看译文

关键词

Perampanel,genetic epilepsies,precision therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要